Back to results
US 5,776,759 AGranted
Two novel human cathepsin proteins
AssigneeIncyte Pharmaceuticals, Inc.
InventorsOlga Bandman, Roger Coleman
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeIncyte Pharmaceuticals, Inc.
InventorsOlga Bandman, Roger Coleman
Estimating the term…
The present invention provides two novel human cathepsin proteins (HCPs) and polynucleotides encoding HCPs. The invention provides for genetically engineered expression vectors and host cells comprising the nucleic acid sequence encoding HCPs. The invention also provides for the production and use of antibodies to HCPs in pharmaceutical compositions for the treatment of disease processes that include cancers, inflammation, metastasis and peptide and proenzyme processing. In addition, the invention provides for the production and use of inhibitors of HSPs in pharmaceutical compositions for the treatment of diseases. The invention also describes diagnostic assays which utilize the polynucleotide to hybridize with the transcripts encoding HCPs. The invention also provides for the use of antisense molecules in pharmaceutical compositions as a therapeutics in cancers, inflammation, metastasis and peptide and proenzyme processing.
An isolated polynucleotide sequence encoding the polypeptide comprising the amino acid sequence of SEO ID NO:1.
An isolated polynucleotide sequence consisting of the nucleic acid sequence of SEQ ID NO:2.
A hybridization probe consisting of SEQ ID NO:2.
An isolated polynucleotide sequence which specifically hybridizes to SEQ ID NO:2.
An isolated polynucleotide sequence consisting of the complement of SEQ ID NO:2.
Dependencies are inferred from the claim text.